Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Comparative efficacy and bioavailability of different praziquantel brands.

Botros S, El-Lakkany N, Seif el-Din SH, Sabra AN, Ibrahim M.

Exp Parasitol. 2011 Feb;127(2):515-21. doi: 10.1016/j.exppara.2010.10.019.

PMID:
21044626
2.

Drug-metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities.

Botros SS, El-Din SH, El-Lakkany NM, Sabra AN, Ebeid FA.

J Parasitol. 2006 Dec;92(6):1344-9.

PMID:
17304818
4.

Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.

Botros S, Mahmoud M, Hammam O, Salah F, Zidek Z, Masek K.

APMIS. 2006 Jul-Aug;114(7-8):480-91.

PMID:
16907853
5.

Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice.

El-Lakkany N, Seif El-Din SH, Heikal L.

Eur J Drug Metab Pharmacokinet. 2012 Dec;37(4):289-99. doi: 10.1007/s13318-012-0089-6.

PMID:
22460595
6.

Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.

El-Feky GS, Mohamed WS, Nasr HE, El-Lakkany NM, Seif El-Din SH, Botros SS.

Antimicrob Agents Chemother. 2015;59(6):3501-8. doi: 10.1128/AAC.04875-14.

7.

Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.

Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL.

Am J Trop Med Hyg. 1996 Aug;55(2):214-8.

PMID:
8780463
8.

Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.

Botros SS, Hammam O, Mahmoud M, Bergquist R.

APMIS. 2010 Sep 1;118(9):692-702. doi: 10.1111/j.1600-0463.2010.02645.x.

PMID:
20718722
10.

Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.

Liang YS, Coles GC, Dai JR, Zhu YC, Doenhoff MJ.

J Helminthol. 2002 Dec;76(4):327-33.

PMID:
12498638
11.

Impact of drug dosage and brand on bioavailability and efficacy of praziquantel.

Metwally A, Bennett J, Botros S, Ebeid F, el attar Gel D.

Pharmacol Res. 1995 Jan;31(1):53-9.

PMID:
7784306
12.
13.

Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation.

de Jesus MB, Pinto Lde M, Fraceto LF, Magalhães LA, Zanotti-Magalhães EM, de Paula E.

J Drug Target. 2010 Jan;18(1):21-6. doi: 10.3109/10611860903131677.

PMID:
19624246
14.

A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.

Tanaka M, Ohmae H, Utsunomiya H, Nara T, Irie Y, Yasuraoka K.

Am J Trop Med Hyg. 1989 Aug;41(2):198-203.

PMID:
2505624
15.

Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.

Botros SS, Doughty BL, Shaker ZA, Akl MM, Sharmy R, Diab TM, Hassanein HI.

Int J Immunopharmacol. 1996 Dec;18(12):707-18.

PMID:
9172014
16.

Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.

Mohamed AH, Ezz El-Din N, Fahmy ZH, El-Shennawy AM, Hassan E.

J Egypt Soc Parasitol. 2006 Apr;36(1):197-220.

PMID:
16605111
17.

Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice.

Abdel-Hafeez EH, Ahmad AK, Abdulla AM, Aabdel-Wahab S, Mosalem FA.

Parasitol Res. 2012 Aug;111(2):577-86. doi: 10.1007/s00436-012-2871-4.

PMID:
22398831
18.

Pharmacokinetics and microsomal oxidation of praziquantel and its effects on the P450 system in three-month-old lambs infested by Fasciola hepatica.

Giorgi M, Salvatori AP, Soldani G, Giusiani M, Longo V, Gervasi PG, Mengozzi G.

J Vet Pharmacol Ther. 2001 Aug;24(4):251-9.

PMID:
11555180
19.

Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.

el-Lakkany NM, el-Din SH, Sabra AN, Hammam OA.

Mem Inst Oswaldo Cruz. 2011 Nov;106(7):814-22.

20.

Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.

Barakat R, El Morshedy H.

Parasitology. 2011 Apr;138(4):440-6. doi: 10.1017/S003118201000154X.

PMID:
21078223
Items per page

Supplemental Content

Support Center